reSee.it - Related Video Feed

Speaker 0: The vaccine works against it or or it's unsure at this point? Speaker 1: Well, we don't know. For the c one two, we don't know. Right now, vaccines do work, but, obviously, they work against hospitalizations and deaths Yeah. Really well. Before just casual breakthrough mild infections with Delta has taught us that there's a lot more breakthroughs than we know. And after six months, it does tend to wane a little bit. And hence, Israel is going for third booster shot starting October 1. Unless you're triple vaxxed, you're not considered fully vaxxed. Speaker 0: Wow. Speaker 1: And that approach, as much as it sucks, is the reality that with the face of these new variants. This is why the sooner we end it, the sooner we can stop dealing with these upgrade software upgrade patches that we have to do with our vaccines. But

Vaccines are seen as magical but expectations should be tempered. Pfizer's vaccine is 95% effective, but efficacy drops over time. Boosters may be needed annually. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but we must adapt.

We have better tools this year to combat the omicron variant, including vaccines, monoclonal antibodies, and effective treatments. It may take a few days to understand how this variant behaves, but we should remain calm and prepared. Ensure you are vaccinated and receive a booster if eligible. Practice common sense precautions: wash your hands, get tested if exposed, and seek well-ventilated areas in public.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

Viruses hijack our cells to replicate themselves, but they make copying errors, leading to random mutations. The more a virus can replicate, the more mutations it can generate. This happens in unvaccinated or immunocompromised individuals. Omicron may have originated in an HIV-infected person with a weak immune system. Mutations that evade the immune system can thrive. However, a strong and vaccinated immune system can effectively fight the virus, preventing or eliminating it faster. Vaccines do not promote mutations; they help prevent them. Studies show that countries with high vaccination rates have fewer mutations.

Vaccination is crucial for protecting oneself and others, and for society to return to normal. Vaccinated individuals are less likely to transmit the virus or get sick. Getting vaccinated and receiving booster shots can save lives and prevent the spread of infection. The goal is to become a dead end for the virus, stopping its transmission. Vaccinated people do not get infected and cannot be used as hosts to spread the virus. However, the initial emergency use authorization did not have sufficient data on the vaccine's effect on transmission. The speed of scientific progress necessitated quick action.

Now that we're coming out of the pandemic, the issue of variants will mainly be discussed by specialists. They will talk about the impact of these variants in conferences. Currently, the planned vaccination covers all variants. And does vaccination limit the emergence of new variants? Absolutely, by reducing the number of affected individuals. It decreases the portion of the population where the virus can multiply and mutate, thus leading to new variants. So, vaccination is absolutely essential to control the situation.

NAZI has authorized the use of updated COVID-19 vaccines for age groups, recommending a dose every 6 months after the last dose or infection. Canada has seen the Omicron variant evolve, including subvariants like XBB and BA.2.86. The updated vaccines are expected to provide better protection against circulating strains. If it has been more than 6 months since the last dose or infection, individual protection may have decreased, making it important to get a vaccine dose this fall. This is especially crucial for those at higher risk, such as older adults, individuals with underlying conditions, pregnant people, and those in congregate living settings. Vaccination and personal protective measures are essential in reducing the impact of respiratory illnesses, especially during colder months when indoor activities increase the risk.

We achieved over 90% efficacy with our vaccine, providing protection against all identified variants, including the challenging South African variant. Studies in South Africa showed 100% efficacy. While two doses offer limited protection against Omicron, three doses are effective against hospitalizations and deaths. A fourth booster may be needed. The Pfizer COVID vaccine was not tested for stopping transmission before market release. No serious adverse events were found in our data analysis. Lawsuits have been filed against Pfizer for alleged misrepresentation of vaccine effectiveness and safety concerns. The success of our vaccine is a significant scientific breakthrough.

If you're eligible for the vaccine and not getting it, you're being irresponsible. The omicron variant is highly contagious, and unvaccinated people will likely get it, putting a strain on healthcare. Almost half of ICU patients are unvaccinated. We need to persuade them to get vaccinated for their own good and the public's. It's crucial to increase vaccination efforts in developing countries.

To have a safe Christmas with our loved ones, it is important to get vaccinated. Vaccination reduces the risk of getting infected by almost half, and if we are not infected, we cannot transmit the virus. Although the Omicron variant is less lethal, it still puts a burden on the healthcare system and can cause long-term effects. Testing and isolating when necessary, along with proper ventilation, can help reduce the chances of transmission. It is also important to continue wearing masks, especially in high-risk places like public transportation. We need to take responsibility and follow these precautions to protect ourselves and others.

Being vaccinated keeps you safe and reduces transmission. Unvaccinated people pose the highest risk of spreading the virus and facing severe illness. Vaccination offers over a 98% chance of avoiding COVID. The third dose provides protection against severe illness and infection. AstraZeneca's vaccine has been approved but faced bans in some countries. Data shows more COVID deaths in vaccinated individuals in the US. The global vaccination trial proves that vaccines are safe and effective.

We need a high booster rate to prevent severe illness. Other countries have seen faster uptake of boosters when Omicron spreads rapidly. Don't wait, get your booster today to fully benefit from the vaccine. The side effects of boosters appear to be milder than the second dose, according to our director general of health.

Vaccination is crucial for protecting oneself and others, allowing society to return to normal. Vaccinated individuals are unlikely to carry or get sick from the virus. Getting vaccinated and receiving booster shots can save lives and prevent the spread of infection. The probability of reducing transmission is believed to be 100%. Taking vaccines not only protects individuals and their families but also breaks the chain of transmission. Vaccinated people do not become infected and cannot spread the virus. However, it was initially unclear if the vaccines would stop transmission, as the data was limited. The speed of scientific progress necessitated quick action.

According to the CDC, vaccinated individuals don't carry or get sick from the virus, both in clinical trials and real-world data. However, reports from international colleagues, like Israel, indicate a higher risk of severe disease among those vaccinated early. This evidence raises concerns that the strong protection against severe infection, hospitalization, and death could decrease in the future, particularly for those at higher risk or vaccinated earlier during the rollout phases.

Vaccines are seen as magical, but expectations may need to be lowered. Pfizer's vaccine is 95% effective, but efficacy rates can fluctuate. Protection may only last a year, requiring annual shots. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but there is hope for improvement in the next 5 years.

Multiple studies have shown the safety and effectiveness of COVID-19 vaccines. In Israel, a study found that the vaccines were 97% effective against symptomatic infection and 86% effective against asymptomatic infection in healthcare workers. In the United States, vaccines were 90% effective against any infection and 94% effective against hospitalizations from COVID-19 in healthcare workers across multiple states. The Pfizer vaccine has also been found to be effective against common variants in the US, such as B117 and B1351. Similar effectiveness has been observed with the Moderna and Johnson & Johnson vaccines. Even if someone does get infected after vaccination, the infection is likely to have a lower viral load, be shorter in duration, and have a lower risk of transmission to others.

Getting the third vaccine dose offers protection against severe illness and reduces the risk of initial infection. However, even with two, three, or four doses, the vaccine is not very effective at preventing infections altogether. This is evident in the tens of thousands of cases reported during this wave.

Vaccination is crucial for protecting oneself and others, and for society to return to normal. Vaccinated individuals are less likely to transmit the virus or get sick. Getting vaccinated and receiving booster shots can save lives and prevent the spread of infection. The goal is to become a dead end for the virus, stopping its transmission. Vaccinated people do not get infected and cannot be used as hosts to spread the virus. However, the initial emergency use authorization did not have sufficient data on the vaccine's effectiveness against transmission. The speed of scientific progress necessitated quick action.

Robert F. Kennedy Jr.: Hi, it's Robert F. Kennedy Jr. here, your HHS secretary. At HHS, we have a division called the Biomedical Advanced Research and Development Authority, or BARDA. BARDA drives some of our most advanced scientific research. It funds developments of vaccines, drugs, diagnostics, and other tools to fight emerging diseases and national health threats. Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Let me explain why. Most of these shots are for flu or COVID, but as the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. This dynamic drives a phenomena called antigenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine. Millions of people, maybe even you or someone you know, caught the omicron variant despite being vaccinated. That's because a single mutation can make mRNA vaccines ineffective. The same risk applies to flu. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. That's why after extensive review, BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions. Thank you. Produced by the U. S. Department of Health and Human Services.

Vaccinated individuals are protected against COVID-19 and its variants, as the vaccines are highly effective. They do not carry the virus, get sick, or transmit it to others. Vaccination allows society to return to normal by reducing transmission. Getting both vaccine shots is crucial. Vaccinated people are safe from hospitalization, ICU stays, and death, and they no longer need to wear masks. However, they cannot prevent transmission. Israel's experience suggests a waning of immunity, indicating the need for booster shots. The plan is for every adult to receive a booster shot. Overall, vaccines have been a highly successful investment.

AstraZeneca is confident that their vaccine is effective, but because the trial participants were young, they don't know if it prevents serious illness or death. However, their own trials show that it does deal with serious disease and hospitalization. It's important to note that the virus will mutate, but the UK has a strong genomic sequencing industry that can quickly identify mutations. The UK is also working with manufacturers to produce vaccines for new variants. This will help boost the nation's protection and future-proof the country.

Vaccinated individuals are protected against COVID-19 and its variants, as the vaccines are highly effective. They do not carry the virus, get sick, or transmit it to others. Vaccination allows society to return to normal. Fully vaccinated people no longer need to wear masks or practice physical distancing, and they are unlikely to be hospitalized or die from the virus. However, vaccines only slightly reduce transmission, and there is a need for new vaccination strategies. Reports from Israel suggest a waning of immunity, indicating the importance of booster shots. The plan is for every adult to receive a booster shot.

Vaccination not only protects individuals but also reduces virus transmission, helping society return to normal. Current data indicates that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and boosted can save lives and prevent serious illness. The goal is to stop the virus from spreading by ensuring vaccinated individuals act as dead ends for transmission. Vaccines are effective enough that when a vaccinated person is exposed, the virus cannot infect them or spread further. However, there was uncertainty about the vaccines' ability to stop transmission at the time of emergency use authorization. The data on this was limited, and it was acknowledged that the speed of development impacted the understanding of transmission prevention.

Vaccines were not expected to fully prevent infection, and this may have caused confusion about their effectiveness against severe disease and hospitalization. While vaccines do help reduce severe outcomes, it's important to note that a significant portion of those who died during the omicron surge were older individuals who were vaccinated. Therefore, whether vaccinated or unvaccinated, the focus should be on testing and the use of paxlovid for treatment.